Farhad Hafezi
Farhad Hafezi[edit | edit source]
Farhad Hafezi is a prominent Swiss eye surgeon and researcher known for his contributions to the field of ophthalmology, particularly in the areas of corneal cross-linking and refractive surgery. He has played a significant role in advancing treatments for keratoconus and other corneal diseases.
Early Life and Education[edit | edit source]
Farhad Hafezi was born in 1967 in Tehran, Iran. He moved to Switzerland at a young age, where he pursued his education. Hafezi completed his medical studies at the University of Fribourg and the University of Bern, where he earned his medical degree. He later specialized in ophthalmology, completing his residency at the University of Geneva.
Career[edit | edit source]
Hafezi's career in ophthalmology has been marked by his innovative research and clinical work. He has held several academic and clinical positions, including serving as a professor at the University of Geneva and the University of Southern California.
Corneal Cross-Linking[edit | edit source]
Hafezi is best known for his pioneering work in corneal cross-linking (CXL), a procedure used to treat keratoconus and other corneal ectatic disorders. This technique involves the use of ultraviolet light and riboflavin (vitamin B2) to strengthen the collagen fibers in the cornea, thereby halting the progression of keratoconus.
Research and Innovations[edit | edit source]
In addition to his work on CXL, Hafezi has contributed to the development of new surgical techniques and technologies in refractive surgery. His research has focused on improving the safety and efficacy of procedures such as LASIK and PRK.
Awards and Recognition[edit | edit source]
Throughout his career, Hafezi has received numerous awards for his contributions to ophthalmology. He is a frequent speaker at international conferences and has published extensively in peer-reviewed journals.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD